Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Short term Debt (2016 - 2025)

INVO Fertility (IVF) has disclosed Short term Debt for 12 consecutive years, with $4.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Short term Debt rose 79.38% to $4.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.5 million, a 79.38% increase, with the full-year FY2024 number at $2.5 million, changed 0.0% from a year prior.
  • Short term Debt was $4.5 million for Q3 2025 at INVO Fertility, down from $5.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $5.0 million in Q1 2025 to a low of $185458.0 in Q1 2021.
  • A 4-year average of $2.5 million and a median of $2.5 million in 2023 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: changed 0.0% in 2024, then skyrocketed 100.0% in 2025.
  • INVO Fertility's Short term Debt stood at $340539.0 in 2021, then skyrocketed by 634.13% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024, then soared by 79.38% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Short term Debt are $4.5 million (Q3 2025), $5.0 million (Q2 2025), and $5.0 million (Q1 2025).